Standard Lithium Ltd vs GeneDx Holdings Corp — how do they compare? Standard Lithium Ltd trades at $2.27 (market cap $523.89M), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: GeneDx Holdings Corp is far larger — about 3.4× Standard Lithium Ltd's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, Standard Lithium Ltd nearer its low. Which is the better fit depends on your goals.
| SLI | WGS | |
|---|---|---|
Market Cap | $523.89M | $1.80B |
Sector | Basic Materials | Technology |
52-Week High | $5.65 | $167.51 |
52-Week Low | $2.15 | $34.51 |
Enterprise Value | $383.09M | $1.80B |
Trailing returns across standard periods
Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →